Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Therapeutics

Health Care

Biotechnology

Innoviva Specialty Therapeutics, Inc.

Steve Basso

Patricia Drake

David Altarac

Marianne Zhen

Marcie Cain

Director Team

Clinical Operations & Development

Critical Care Team

Leadership Team

Medical Affairs Team

Finance & Accounting Team